Stablecoin Development Corp.
SDEV
AMEX·Healthcare·Medical - Pharmaceuticals·Mkt cap $44.9M
$0.89
▼ -0.08%
P/E
—
Mkt Cap
$44.9M
52-Wk Range
$0.83–$2.13
52-Week Range
$0.83 - $2.13
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 28.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.1).
Growth
Profitability at risk
Value
Valuation data unavailable
Momentum
Falling
-23.3% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying SDEV right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
JUL 30, 2026
Reported EPS of $0.01 vs -$0.55 consensus (+101.8% surprise). Revenue of $2.2M vs $3.3M expected (-33.1%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+101.8%
Revenue trend · last 2Q
—
—
Q1 26
Q2 26
$2.5M
$2.2M
Margins · last 2Q
Gross
0.0%
Operating
-145.6%
Profit
-1861.7%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How SDEV stacks vs Medical - Pharmaceuticals
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.